MARKET IS CLOSED
Loading latest tickers...

Market Indices

S&P 500
$7,801.77
-0.22%
NASDAQ 100
$31,160.08
-0.21%
DOW JONES
$51,180.00
-0.66%
NASDAQ Composite
$27,538.69
-0.22%
RUSSELL 2000
$2,777.00
-1.29%
CBOE VIX
$15.08
+0.47%

Sector Heatmap

Technology-0.30%
Financials-0.48%
Healthcare+1.03%
Consumer Cycl-0.32%
Consumer Staples-0.12%
Energy-0.58%
Industrials-2.18%
Materials-1.51%
Real Estate-1.29%
Utilities-0.02%
Comm Services-0.35%

PEN — Penumbra, Inc.

NYSE

Penumbra, Inc.

CompareBack to Screener
$316.35
-0.70(-0.22%)
O
316.62
H
317.74
L
316.32
V
363.84K
⏱️ End-of-day dataAs of Oct 7, 2026

Chart

About PEN

Domiciled in the US, Penumbra designs, manufactures, and markets an array of thrombectomy and embolization devices and equipment to mechanically remove blood clots. The firm sells mainly to hospitals and physicians. These minimally invasive devices are primarily used in the acute care setting for patients with stroke, pulmonary embolism, deep vein thrombosis, cranial aneurysms, and other vascular diseases.

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS
SectorNot available
IPO DateSep 18, 2015
Employees4,700
Stock ExchangeNYSE
Ticker SymbolPEN

Key Financial Statistics

Market Cap$12.51B
P/E RatioN/A
Dividend YieldNone
EPSN/A
BetaN/A
52-Week Range$221.26 - $362.41
52-Week Avg Volume566.2K
VWAP$317.09
Transactions12,587
Total Recorded Bars2,779 days